US › Healthcare

Impact BioMedical, Inc. (IBO)

US · Healthcare · Biotechnology

$0.44+0.23%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$7,000
Net profit
$-2.3M
Profit YoY
-80.5%
EPS
$-0.02
Net margin
-32,671.4%

Key statistics

Market cap
$47.3M
Forward P/E
0.0
P/B
4.04
Book value
$0.11
EPS (TTM)
$-0.29
52-week high
$0.83
52-week low
$0.37
50-day MA
$0.50
200-day MA
$0.53

Shareholding

Insiders
89.02%
Institutions
3.45%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Impact BioMedical, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.